Researched applications In the published preclinical and clinical literature the effects of AOD-9604 are documented in the following areas: Obesity , Phase 2b failure (2007), but a complementary mechanism in combination protocols Lipolysis in animal models , robustly demonstrated (Heffernan 2001, Ng 2009) Inhibition of lipogenesis , demonstrated in hepatocytes and adipocytes Osteoarthritis and cartilage regeneration , emerging Phase 1/2 data (mLuna Pharmaceuticals 2018+) Tendinopathy , preclinical models Age-related sarcopenia (cachexia) , exploratory plans Lipodystrophy , preclinical data in animal models Hyperlipidemia , secondary endpoints in Phase 2 trials Science & studies 4.1 Key publications Heffernan M., Summers R.J., Thorburn A., et al
Your anorexia is obviously going to be a contributary factor to your B12 deficiency and other health issues
That upstream tweak can ripple through energy, fat storage, and cellular stress less biochemical drag, more efficient housekeeping
Premium Methylcobalamin B12 (1mg x 10) Manufactured in Germany
B12 medicines contain cobalt, and the MHRA advises extra vigilance for sensitivity reactions in people with known cobalt allergy.Always tell your clinician about allergies before treatment